CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: December 17, 2014
Result type: Reports
Project Number: SR0409-000
Product Line: Reimbursement Review

Generic Name: Linaclotide

Brand Name: Constella

Manufacturer: Actavis Specialty Pharmaceuticals Co.

Therapeutic Area: Irritable bowel syndrome with constipation

Indications: Irritable bowel syndrome with constipation

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: September 23, 2015

Recommendation Type: Do not list

Request for Resubmission: Not Eligible (December 13, 2017)